Detalhe da pesquisa
1.
Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase 1b study (GO28440).
Haematologica
; 106(11): 2834-2844, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33121235
2.
A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies.
Cancer
; 125(10): 1629-1636, 2019 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30645764
3.
Real-world clinical experience in the Connect® chronic lymphocytic leukaemia registry: a prospective cohort study of 1494 patients across 199 US centres.
Br J Haematol
; 175(5): 892-903, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27861736
4.
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors.
Invest New Drugs
; 32(4): 700-9, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24711126
5.
Sunitinib in combination with trastuzumab for the treatment of advanced breast cancer: activity and safety results from a phase II study.
BMC Cancer
; 14: 166, 2014 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24606768
6.
Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer.
BMC Cancer
; 14: 5, 2014 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-24386952
7.
TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first-line treatment of metastatic colorectal cancer: A randomized phase 1b/2 trial.
Cancer
; 119(24): 4290-8, 2013 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24122767
8.
Clinical outcomes in elderly patients with metastatic colorectal cancer receiving bevacizumab and chemotherapy: results from the BRiTE observational cohort study.
Oncology
; 78(5-6): 329-39, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20733336
9.
Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study.
Lancet Oncol
; 10(3): 247-57, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19201650
10.
Clinical Assessment of 5-Fluorouracil/Leucovorin, Nab-Paclitaxel, and Irinotecan (FOLFIRABRAX) in Untreated Patients with Gastrointestinal Cancer Using UGT1A1 Genotype-Guided Dosing.
Clin Cancer Res
; 26(1): 18-24, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31558477
11.
Prospective International Randomized Phase II Study of Low-Dose Abiraterone With Food Versus Standard Dose Abiraterone In Castration-Resistant Prostate Cancer.
J Clin Oncol
; 36(14): 1389-1395, 2018 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29590007
12.
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neck.
Clin Cancer Res
; 10(15): 4922-32, 2004 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15297392
13.
A phase 1B study of dulanermin in combination with modified FOLFOX6 plus bevacizumab in patients with metastatic colorectal cancer.
Clin Colorectal Cancer
; 12(4): 248-54, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24075777
14.
A phase II study of lapatinib in recurrent/metastatic squamous cell carcinoma of the head and neck.
Clin Cancer Res
; 18(8): 2336-43, 2012 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22371453
15.
Safety and efficacy of combining sunitinib with bevacizumab + paclitaxel/carboplatin in non-small cell lung cancer.
J Thorac Oncol
; 5(3): 354-60, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20032789
16.
Ethnic differences and functional analysis of MET mutations in lung cancer.
Clin Cancer Res
; 15(18): 5714-23, 2009 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19723643
17.
A phase II study of ABT-751 in patients with advanced non-small cell lung cancer.
J Thorac Oncol
; 3(6): 631-6, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18520803